Kosali Ilayperuma

Jul 29, 2024 | rand.org | Kosali Ilayperuma |Ashley Bradford |Thuy Nguyen |Thủy Nguyễn |Lucy B Schulson

BackgroundHow state opioid policy environments with multiple concurrent policies affect opioid prescribing to individuals with acute pain is unknown. ObjectiveTo examine how prescription drug monitoring programs (PDMPs), pain management clinic regulations, initial prescription duration limits, and mandatory continued medical education affected total and high-dose prescribing. DesignA county-level multiple-policy difference-in-difference event study framework.

Jun 2, 2023 | rand.org | Ashley Bradford |Erin Taylor |Erin Audrey |Kosali Ilayperuma

ImportanceA significant proportion of Medicare beneficiaries have a diagnosed opioid use disorder (OUD). Methadone and buprenorphine are both effective medications for the treatment of OUD (MOUDs); however, Medicare did not cover methadone until 2020. ObjectiveTo examine trends in methadone and buprenorphine dispensing among Medicare Advantage (MA) enrollees after 2 policy changes in 2020 related to methadone access.